Immediate Impact

66 standout
Sub-graph 1 of 23

Citing Papers

Cancer treatment and survivorship statistics, 2022
2022 Standout
Treatment of epithelial ovarian cancer
2020 Standout
2 intermediate papers

Works of Steve Waggoner being referenced

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study
2011
Race and Clinical Outcome in Patients with Carcinoma of the Uterine Cervix Treated with Radiation Therapy
1998

Author Peers

Author Last Decade Papers Cites
Steve Waggoner 595 313 208 236 14 778
Sherry Breaux 457 377 237 122 15 758
H Pourquier 580 396 241 179 31 798
Mary Ann Hederman 343 285 199 103 12 699
J. Demanes 414 299 87 100 17 704
Robert Hudej 542 363 66 108 17 707
G.A. Rawlings 432 487 198 253 21 863
Rutledge Fn 375 300 207 331 22 796
C. Levenback 375 342 181 125 16 686
Mary Ann Lockett 263 338 116 82 14 798
Valentin Harter 281 365 70 92 28 704

All Works

Loading papers...

Rankless by CCL
2026